IBUPROFEN suspension

Land: USA

Språk: engelsk

Kilde: NLM (National Library of Medicine)

Kjøp det nå

Last ned Preparatomtale (SPC)
11-06-2020

Aktiv ingrediens:

Ibuprofen (UNII: WK2XYI10QM) (Ibuprofen - UNII:WK2XYI10QM)

Tilgjengelig fra:

Preferred Pharmaceuticals Inc.

Administreringsrute:

ORAL

Resept typen:

PRESCRIPTION DRUG

Indikasjoner:

Carefully consider the potential benefits and risks of ibuprofen oral suspension and other treatment options before deciding to use ibuprofen. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). In Pediatric Patients, Ibuprofen Oral Suspension is indicated: In Adults, Ibuprofen Oral Suspension is indicated: Since there have been no controlled trials to demonstrate whether there is any beneficial effect or harmful interaction with the use of ibuprofen in conjunction with aspirin, the combination cannot be recommended (see PRECAUTIONS-Drug Interactions ). Ibuprofen is contraindicated in patients with known hypersensitivity to ibuprofen. Ibuprofen should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see WARNINGS-Anaphylactoid Reactions, and PRECAUTIONS-Preexistin

Produkt oppsummering:

Ibuprofen Oral Suspension USP, 100 mg/5 mL White to off-white, berry-flavored suspension - Bottles of 4 fl oz (118 mL) - NDC 51672-1385-8 - Bottles of ONE PINT (473 mL) - NDC 51672-1385-9 Shake well before using. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature.] Dispense in a well-closed container as defined in the USP.

Autorisasjon status:

Abbreviated New Drug Application

Informasjon til brukeren

                                IBUPROFEN- IBUPROFEN SUSPENSION
Preferred Pharmaceuticals Inc.
----------
MEDICATION GUIDE FOR NONSTEROIDAL
ANTI-INFLAMMATORY DRUGS (NSAIDS)
What is the most important information I should know about medicines
called Nonsteroidal Anti-
inflammatory Drugs (NSAIDs)?
NSAIDs can cause serious side effects, including:
•
Increased risk of a heart attack or stroke that can lead to death.
This risk may happen early in
treatment and may increase:
•
with increasing doses of NSAIDs
•
with longer use of NSAIDs
Do not take NSAIDs right before or after a heart surgery called a
"coronary artery bypass graft (CABG)."
Avoid taking NSAIDs after a recent heart attack, unless your
healthcare provider tells you to. You may
have an increased risk of another heart attack if you take NSAIDs
after a recent heart attack.
•
Increased risk of bleeding, ulcers, and tears (perforation) of the
esophagus (tube leading from the
mouth to the stomach), stomach and intestines:
•
anytime during use
•
without warning symptoms
•
that may cause death
The risk of getting an ulcer or bleeding increases with:
•
past history of stomach ulcers, or stomach or intestinal bleeding with
use of NSAIDs
•
taking medicines called "corticosteroids", "anticoagulants", "SSRIs",
or "SNRIs"
•
increasing doses of NSAIDs
•
longer use of NSAIDs
•
smoking
•
drinking alcohol
•
older age
•
poor health
•
advanced liver disease
•
bleeding problems
NSAIDs should only be used:
•
exactly as prescribed
•
at the lowest dose possible for your treatment
•
for the shortest time needed
What are NSAIDs?
NSAIDs are used to treat pain and redness, swelling, and heat
(inflammation) from medical conditions
such as different types of arthritis, menstrual cramps, and other
types of short-term pain.
Who should not take NSAIDs?
Do not take NSAIDs:
•
if you have had an asthma attack, hives, or other allergic reaction
with aspirin or any other NSAIDs.
•
right before or after heart bypass surgery.
Before taking NSAIDs, tell your healthcare provider about 
                                
                                read_full_document
                                
                            

Preparatomtale

                                IBUPROFEN- IBUPROFEN SUSPENSION
PREFERRED PHARMACEUTICALS INC.
----------
IBUPROFEN
ORAL SUSPENSION USP, 100 MG/5 ML
RX ONLY
CARDIOVASCULAR THROMBOTIC EVENTS
•
•
GASTROINTESTINAL RISK
•
DESCRIPTION
The active ingredient in ibuprofen oral suspension USP is ibuprofen,
which is a member of the
propionic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs).
Ibuprofen is a racemic mixture
of [+]S- and [-]R-enantiomers. It is a white to off-white crystalline
powder, with a melting point of 74°
to 77°C. It is practically insoluble in water (< 0.1 mg/mL), but
readily soluble in organic solvents such
as ethanol and acetone. Ibuprofen has a pKa of \4.43 ± 0.03 and an
n-octanol/water partition coefficient
of 11.7 at pH 7.4. The chemical name for ibuprofen is
(±)-2-(_p_-Isobutylphenyl) propionic acid. The
molecular weight of ibuprofen is 206.28. Its molecular formula is C
H O and it has the following
structural formula:
Ibuprofen oral suspension USP is a sucrose-sweetened, white to
off-white, berry-flavored suspension
containing 100 mg of ibuprofen in 5 mL (20 mg/mL). Inactive
ingredients include: acesulfame potassium,
berry flavor natural & artificial, citric acid anhydrous, glycerin,
pregelatinized modified starch,
polysorbate 80, sodium benzoate, purified water, sucrose, xanthan gum.
Meets USP Dissolution Test 2.
Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk
of serious
cardiovascular thrombotic events, including myocardial infarction and
stroke, which can be
fatal. This risk may occur early in treatment and may increase with
duration of use (see
WARNINGS and PRECAUTIONS).
Ibuprofen oral suspension is contraindicated in the setting of
coronary artery bypass graft
(CABG) surgery (see CONTRAINDICATIONS and WARNINGS).
NSAIDs cause an increased risk of serious gastrointestinal adverse
events including
bleeding, ulceration, and perforation of the stomach or intestines,
which can be fatal. These
events can occur at any time during use and without warning symptoms.
Elderly patients are
at 
                                
                                read_full_document
                                
                            

Søk varsler relatert til dette produktet